化工社化工社 化学情報印刷レポート · 研究参考用
オキシメタゾリン
2-(4-tert-ブチル-3-ヒドロキシ-2,6-ジメチルベンジル)-2-イミダゾリン · 2,4-ジメチル-3-[(2-イミダゾリン-2-イル)メチル]-6-tert-ブチルフェノール · ナビシン · シネロール · ネゼリル · オキシメタゾリン · 3-[(4,5-ジヒドロ-1H-イミダゾール-2-イル)メチル]-6-(1,1-ジメチルエチル)-2,4-ジメチルフェノール · ハゾール

識別子と物理属性
| CAS No. | 1491-59-4 |
|---|---|
| 分子式 | C16H24N2O |
| 平均分子量 | 260.37 g/mol |
| 単同位体質量 | 260.18886339 g/mol |
| SMILES | Cc1cc(C(C)(C)C)c(O)c(C)c1CC1=NCCN1 |
| InChIKey | WYWIFABBXFUGLM-UHFFFAOYSA-N |
| PubChem CID | 4636 |
| ChEMBL | CHEMBL762 |
| ChEBI | CHEBI:7862 |
| EC No. | 216-079-1 |
| DTXSID | DTXSID3040691 |
| 現地名 | オキシメタゾリン |
化学・物理的性質
| XLogP | 2.9 |
|---|---|
| 極性表面積 | 44.6 |
| 水素結合供与体数 | 2 |
| 水素結合受容体数 | 2 |
| 回転可能結合数 | 3 |
| 重原子数 | 19 |
| 形式電荷 | 0 |
| 複雑度 | 345 |
| 医薬品 | Pharmaceuticals -> Listed in ZINC15 |
| LogP(分配係数) | 3.4 |
| Color/Form | Crystals from benzene |
| 溶解度 | ODORLESSWHITE TO NEARLY WHITE, FINE, CRYSTALLINE POWDERSOL IN ALCMol wt 296.84. Crystals, dec 300-303 °C. Freely sol in water, alcohol. Practically insol in ether, chloroform, benzene /Hydrochloride/Insoluble in diethyl ether, chloroform, and benzene5.15e-02 g/L |
| Human Drugs | Breast FeedingLactationMilk, HumanAdrenergic alpha-AgonistsSympathomimeticsNasal DecongestantsFDA approved drugs -> Active ingredientPharmaceuticals |
| Decomposition | When heated to decomposition it emits toxic fumes of /nitrogen oxides/. |
| 融点 | 181-183 °C182 °C |
| Physical Description | Solid |
| Stability/Shelf Life | STABLE IN LIGHT & HEAT, & IS NONHYGROSCOPIC /HYDROCHLORIDE/ |
| Collision Cross Section | 163.86 Ų [M+Na]+ [CCS Type: TWMethod: calibrated with polyalanine and drug standards] |
| 沸点 | 403.63°C (rough estimate) |
| 密度 | 0.9822 (rough estimate) |
| 屈折率 | 1.5800 (estimate) |
| pKa(酸解離定数) | 11.93±0.28(Predicted) |
| 色 | C6H6からの結晶 |
| InChI | InChI=1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18) |
| InChIKey | WYWIFABBXFUGLM-UHFFFAOYSA-N |
| SMILES | C1(O)=C(C(C)(C)C)C=C(C)C(CC2NCCN=2)=C1C |
| CAS データベース | 1491-59-4(CAS DataBase Reference) |
| NISTの化学物質情報 | Oxymetazoline(1491-59-4) |
安全性と法規制
| GHS 分類 | DangerH300+H330 (96.6%): Fatal if swallowed or if inhaled [Danger Acute toxicity, oralacute toxicity, inhalation]P260, P264, P264+P265, P270, P271, P273, P280, P284, P301+P316, P304+P340, P305+P354+P338, P316, P317, P320, P321, P330, P403+P233, P405, and P501 (click each P-code to see the statement)Aggregated GHS information provided per 29 reports by companies from 2 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies. |
|---|---|
| 規制情報 | Chemical: Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl-Status: Active Update: 06-02-2018 https://echa.europa.eu/registration-dossier/-/registered-dossier/22185 |
| その他の安全情報 | IMAP assessments - Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl-: Environment tier I assessment |
| FDA 要件 | Nasal decongestant active ingredients. The active ingredient of the product consists of any of the following when used within the dosage limits and in the dosage forms established for each ingredient: ... Topical nasal decongestants: Oxymetazoline hydrochloride. /Oxymetazoline hydrochloride/The Approved Drug Products with Therapeutic Equivalence Evaluations List identifies currently marketed over-the-counter drug products, incl oxymetazoline, approved on the basis of safety and effectiveness by FDA under sections 505 of the Federal Food, Drug, and Cosmetic Act. |
| Special Reports | Gilstrap LC, Little BBDrugs & Pregnancy 269-75 (1992). Antihistamines, decongestants, and expectorants during pregnancy.Smith MB, Feldman WJAMA 269: 2256-63 (1993). Over the counter cold medications: critical review of clinical trials between 1950 and 1991. |
| Hazard Classes and Categories | Acute Tox. 1 (100%) |
| 保管条件 | Oxymetazoline hydrochloride nasal solutions should be stored in tight containers at a temperature less than 40 °C, preferably at 2-30 °Cfreezing should be avoided. Oxymetazoline hydrochloride ophthalmic solutions should be stored at 15-30 °C. Oxymetazoline is probably degraded in the presence of aluminum and, therefore, should not be stored in aluminum containers. |
用途
用途
オキシメタゾリン(Oxymetazoline)は、選択的α1作動性?部分的α2作動性局所充血除去薬(英語版)である。 オキシメタゾリンは医療用としては「上気道の諸疾患の充血?うっ血」(耳鼻科用)、「表在性充血(原因療法と併用)」(眼科用)に対して承認されている。一般用医薬品(OTC)としての効能?効果は「急性鼻炎、アレルギー性鼻炎または副鼻腔炎による鼻づまり」である。 血管収縮作用を有する事から、鼻血の止血に対する有効性が報告されている。
使用
Oxymetazoline is used for the same indications as naphazoline, primarily for rhinitis.